The goal of the iPLEDGE REMS is to mitigate the risk of embryo-fetal toxicity.
Similar Posts
Ashfiat Alharamain Energy Support may be harmful due to hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use Ashfiat Alharamain Energy Support, a product promoted and sold for male sexual enhancement on various websites, including Amazon.com (Akkarco, LLC storefront), and possibly in some retail stores.FDA Focuses on Closing the Clinical Trial Reporting Gap for Research Integrity
The FDA is committed to ensuring data transparency by promoting timely registration and reporting of results information to ClinicalTrials.gov.Healwell Homeo Private Limited – 706206 – 06/12/2025
CGMP/Finished Pharmaceuticals/AdulteratedInfusion Pump Correction: ICU Medical, Inc. Issues Correction for Plum Duo Infusion System Due to Software Possibly Resulting in Pump Becoming Unresponsive
ICU Medical is correcting the Plum Duo infusion system due to pump software issues that may cause the device to become unresponsive.Stellalife, Inc. – 712804 – 09/16/2025
Unapproved New Drugs/MisbrandedMatrixx Initiatives Inc. (Zicam), Scottdale, AZ 483 issued 5/28/2009, EIR signed 5/27/2005, and 483 issued 5/27/2005 (23 pages)
Matrixx Initiatives Inc. (Zicam), Scottdale, AZ 483 issued 5/28/2009, EIR signed 5/27/2005, and 483 issued 5/27/2005 (23 pages)